Palo Alto, CA, United States of America

Michael Koehler

This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 2013.


Average Co-Inventor Count = 18.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Koehler: Innovator in Pharmaceutical Compounds

Introduction

Michael Koehler is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical use. His work focuses on addressing immunological and hyperproliferative disorders through innovative chemical compositions.

Latest Patents

Michael Koehler holds 1 patent for his invention titled "Tricyclic heterocyclic compounds, compositions and methods of use thereof." This patent provides novel compounds of a specific formula, which can be utilized in pharmaceutically acceptable compositions. The compounds are designed for the treatment of various medical conditions, showcasing Koehler's commitment to advancing healthcare solutions.

Career Highlights

Koehler is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His role at Genentech allows him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical research and development.

Collaborations

Some of Michael Koehler's notable coworkers include Phillippe Bergeron and Hazel Joan Dyke. Their collaborative efforts contribute to the innovative environment at Genentech, fostering advancements in medical science.

Conclusion

Michael Koehler's work exemplifies the impact of innovation in the pharmaceutical industry. His patent for tricyclic heterocyclic compounds highlights his dedication to improving treatment options for patients. Through his career at Genentech, he continues to make strides in the field of medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…